Abstract
Certain fluoroquinolone antibiotics affect theophylline (THEO) disposition by inhibition of its metabolism, yet no studies to date have investigated the relationship between fluoroquinolone plasma concentration and THEO pharmacokinetics. The effects of two fluoroquinolones, enoxacin (ENOX) and ciprofloxacin (CIPRO), have been studied in male Sprague-Dawley rats (n = 33–46) at steady state plasma concentrations of 0–33 mg · 1−1, achieved by supplementing an intravenous bolus dose with a constant rate infusion. The effects of steady state ENOX and CIPRO plasma concentrations on the clearance of THEO determined after an intravenous bolus dose of 6 mg · kg−1 were described using a competitive inhibition model. The model consisted of two components, one describing a residual component of THEO clearance, which was unaffected by fluoroquinolone, the other describing the non-linear reduction of THEO clearance by fluoroquinolone. The residual clearance estimated from the model was comparable to renal clearance for THEO in the rat. The potency of each fluoroquinolone was characterised by a Ki value, the concentration reducing THEO clearance by 50% of the maximum change. These values were 4.7 µM and 16.3 µM for ENOX and CIPRO, respectively. Thus, in this study, ENOX was found to be a more potent inhibitor of THEO clearance than CIPRO. The method allowed direct in vivo comparison of potency between different fluoroquinolones, as pharmacokinetic differences, such as clearance, volume of distribution and bioavailability, were ‘designed out.’
Similar content being viewed by others
REFERENCES
W. J. A. Wijnands, T. B. Vree and C. L. A. van Herwaarden. The influence of quinolone derivatives on theophylline clearance. Br. J. Clin. Pharmac. 22:677–683 (1986).
D. J. Edwards, S. K. Bowles, C. K. Svensson and M. J. Rybak. Inhibition of drug metabolism by quinolone antibiotics. Clin. Pharmacokin. 15:194–204 (1988).
J. Beckmann, W. Elsaßer W, U. Gundert-Remy and R. Hertrampf. Enoxacin—a potent inhibitor of theophylline metabolism. Eur. J. Clin. Pharmacol. 33:227–230 (1987).
M. C. Rogge, W. R. Solomon, A. J. Sedman, P. G. Welling, R. D. Toothaker and J. G. Wagner. The theophylline-enoxacin interaction: I. Effect of enoxacin dose size on theophylline disposition. Clin. Pharmacol. Ther. 44(5):579–587 (1988).
Y. Mizuki, M. Kamaura, T. Yamaguchi, Y. Sekine and M. Hashimoto. Interaction of enoxacin with theophylline in rats. Arzneim.-Forsch./Drug Res. 39:593–597 (1989).
R. A. Robson, E. J. Begg, H. C. Atkinson, D. A. Saunders, C. M. Frampton. Comparative effects of ciprofloxacin and lom-efloxacin on the oxidative metabolism of theophylline. Br. J. Clin. Pharmacol. 29(4):491–493 (1990).
F. Sörgel, G. Mahr, G. R. Granneman, U. Stephan, P. Nickel, P. Muth. Effects of 2 quinolone antibacterials, temafloxacin and enoxacin, on theophylline pharmacokinetics. Clin. Pharmacokinet. 22(suppl 1):65–74 (1992).
P. G. Harns and S. R. Ojeda. A rapid and simple procedure for chronic cannulation of the rat jugular vein. J. Appl. Physiol. 36:391–392 (1974).
J. D. Davis, L. Aarons and J. B. Houston. Simultaneous assay of fluoroquinolone and theophylline in plasma by high performance liquid chromatography. J. Chromatogr. (Biomed Applic) 621:105–109 (1993).
H. M. Siefert, D. Maruhn, W. Maul, D. Förster and W. Ritter. Pharmacokinetics of ciprofloxacin. Arzneim.-Forsch./Drug Res. 36(10):1496–1502 (1986).
D. Matthew and J. B. Houston. Drug metabolising capacity in vitro and in vivo I. Correlations between hepatic microsomal mono-oxygenase markers in β-naphthoflavone-induced rats. Biochem. Pharmacol. 40:743–749 (1990).
M. W. E. Teunissen, I. O. N. Brorens, J. M. Geerlings and D. D. Breimer. Dose dependent elimination of theophylline in rats. Xenobiotica 15:165–171 (1985).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Davis, J.D., Aarons, L. & Houston, J.B. Relationship Between Enoxacin and Ciprofloxacin Plasma Concentrations and Theophylline Disposition. Pharm Res 11, 1424–1428 (1994). https://doi.org/10.1023/A:1018991822440
Issue Date:
DOI: https://doi.org/10.1023/A:1018991822440